麻豆传媒

Dermatology >

Skin Cancer

News, opinions and meeting coverage in dermatology.

A woman rests on her arms at a table while holding a glass of red wine

'Surprising' Number of Cancer Survivors Use Alcohol

Clinicians urged to step up alcohol screening at regular intervals, intervention

A photo of a woman with a swollen chin taken from two angles

What Is Causing This Woman's Swollen Chin?

A long and challenging diagnostic path with twists and turns

ACR over a photo of Georgia World Congress Center in Atlanta, Georgia.

Rheumatoid Arthritis Is No Bar to Cancer Immunotherapy

Small study finds flares common with checkpoint inhibitors, but few patients stopped treatment because of them

A photo of a dermatologist examining the skin of a patient.

Second Primary Melanoma Increases Risk for Death

Data a reminder of the importance of regular skin exams

EULAR over a photo of IFEMA Feria de Madrid.

No Cancer Risk Found With TNF Inhibitors in Psoriatic Arthritis

Expected cancer cases similar to those in general populace, study shows

ASCO over a photo of McCormick Place in Chicago.

Depth of Tumor Response a Better Survival Predictor

Could improve on RECIST as outcome measure in oncology

The sun shining down on melanoma on the skin.

Predicting Disease Recurrence in Melanoma

But time to recurrence may poorly correlate with survival

Sheraton Grand hotel in Chicago with ACR-SOTA text overlaid.

Rheumatologist's Primer on Checkpoint Inhibitors

Specialist reviews the landscape of cancer drugs' autoimmune side effects

A photo of the Georgia World Conference Center with the acronym AACR overlaid

Reversing Melanoma Resistance to Immunotherapy

HDAC inhibitor/anti-PD-1 combo active after initial anti-PD-1 failure

Cancer Drug for Precancerous Lesions?

Fluorouracil cream bested other common actinic keratosis treatments

Do Keloids Convey a Higher Cancer Risk?

Taiwanese researchers show association between raised scars and cancers

V600K-Mutant Melanoma May Merit First-Line Immunotherapy

Higher mutational load is less responsive to targeted therapy with BRAF/MEK inhibition

AHA: Targeting Inflammation With Methotrexate Flops for CV Prevention

CIRT trial disappoints after CANTOS' win for the inflammatory hypothesis

NCRI: Highlights from the Annual Conference

Prostate cancer tradeoffs, rising melanoma mortality, safer regimen for thyroid cancer

Ideal Timing of Post-Mohs Reconstruction

Waiting 7 days or more associated with reduced complications

SBRT Doubles 5-Year Survival in Oligometastatic Cancers

Most patients in phase II trial had up to three metastatic lesions

Frequent Basal Cell Cancers Sign of Broader Inherited Risk

Tripled rates of internal malignancies such as breast and prostate tumors

Study: Paclitaxel Best for HIV-Related Kaposi's Sarcoma

Other chemotherapies fall behind in resource-limited setting

Risk Factors for Ipilimumab-Induced Hypophysitis Remain Unclear

Researchers recommend close monitoring of these patients

Vermilion Lip Cancer Tied to Higher Risk of Spread

If confirmed, findings may merit inclusion in staging criteria

Morning Break: Stolen Trump Records; Gyns in Trouble; Eye Cancer Cluster?

Health news and commentary from around the Web gathered by the 麻豆传媒 staff

PAs Fare Worse Than Derms for Skin Cancer Diagnosis

AAPA/SDPA call study 'fundamentally flawed'

Adjuvant Anti-PD-1 Scores Again in Melanoma

Recurrence risk falls by more than 40% with pembrolizumab

NCCN: Don't Let HIV Status Dictate Cancer Treatment

New guidelines focus on most common cancers in HIV-infected patients

Make the Diagnosis: Itchy Fingers from IV Therapy?

Case Findings: A 48-year-old woman who was receiving IV immunoglobulin therapy complained to her doctor that over the past few weeks small vesicles had formed along the sides of her fingers. Some had ruptured and become scaly papules. Her fingers were extremely pruritic, and she said it was "driving her crazy." Can you diagnose the patient?

Gene Expression Test Impacts Melanoma Management

Test assessed high-risk patients based on biological data from 31 genes in tumor tissue

AAD 2018: Emphasis on 'Adult' Education, Engagement

More hands-on sessions, direct participant involvement

McCain Recovery: How Long Will It Take?

麻豆传媒 Experts Weigh In

MSK Cancer Alliance: Mainly About Medicine

Bi-directional relationship strengthens regional cancer care

Brief, Broad-Area Treatment Clears Actinic Keratosis

High patient satisfaction with ingenol disoxate

Transplant Patients Have More Infections After Mohs Surgery

Immunosuppressed populations significantly prone to post-procedure complications

Make the Diagnosis:聽Callus Conundrum

Case Findings: A 52-year-old man presents with possible calluses on either side of his thumb, forefinger, and middle finger. He reports cutting them off with nail clippers, but they return. He also reports using an over-the-counter wart treatment without success. What is your diagnosis?

Make the Diagnosis: More Than A Rash

Case Findings: A 51-year-old woman visited her primary care doctor complaining of a rash, pruritus, myalgias, and muscle weakness that made normally easy tasks like standing from a seated position difficult. The rash was an erythematous blanching patch, spread across her back and shoulders like a shawl and across her chest in a V shape. She had also noticed that her fingernail folds were red and swollen. What is your diagnosis?

10 Questions: Ilona J. Frieden, MD

'The structure of the system itself is the biggest barrier'

FDA Approves Drug for Basal Cell Carcinoma

Sonidegib becomes second hedgehog inhibitor for locally advanced disease.

Viagra and Melanoma: Is There a Link?

Perry Wilson, MD, gives his take on Viagra, Cialis, and skin cancer

New Melanomas Likely to Recur at Same Rate

CHICAGO -- A diagnosis of in situ or invasive melanoma conferred a similar long-term risk of invasive melanoma recurrence, a 40-year retrospective review showed.

ASCO: Targeting PD-1 Works in Advanced Melanoma

CHICAGO -- Two studies indicate that using investigative immunotherapy drugs improves survival and response in patients with metastatic melanoma, researchers said here.

ASCO: Ipilimumab Cuts Relapse but Safety Issues Remain

CHICAGO -- High-risk melanoma patients have a reduced level of relapse if they are taking the monoclonal antibody ipilimumab (Yervoy) when compared with placebo, researchers said here.

OncoBriefs: Myeloma Tx, In Situ Melanoma

Superficial melanoma conferred a risk of recurrent invasive melanoma similar to that of primary invasive melanoma, Australian investigators reported. The study is one of several oncology-related news items summarized in OncoBriefs.

3